HealthCor Management’s Hologic HOLX Stock Holding History

HealthCor Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-137,330	Closed	-$8.86M	–	39
2022 Q3	$8.86M	Sell	137,330 -264,780	-66%	-$18.3M	1.11%	31
2022 Q2	$27.9M	Buy	+402,110	New	+$29.9M	2.8%	10
2021 Q1	–	Sell	-1,017,280	Closed	-$74.1M	–	92
2020 Q4	$74.1M	Buy	+1,017,280	New	+$71.8M	2.86%	14
2020 Q2	–	Sell	-625,240	Closed	-$21.9M	–	58
2020 Q1	$21.9M	Sell	625,240 -1,838,800	-75%	-$87.5M	0.94%	30
2019 Q4	$129M	Buy	2,464,040 +1,654,470	+204%	+$82.4M	4.59%	4
2019 Q3	$40.9M	Buy	+809,570	New	+$39.8M	1.55%	30
2018 Q3	–	Sell	-345,900	Closed	-$13.8M	–	49
2018 Q2	$13.8M	Buy	+345,900	New	+$13.3M	0.44%	41
2017 Q3	–	Sell	-1,688,060	Closed	-$76.6M	–	45
2017 Q2	$76.6M	Buy	+1,688,060	New	+$74.5M	2.76%	13
2017 Q1	–	Sell	-452,340	Closed	-$18.1M	–	43
2016 Q4	$18.1M	Sell	452,340 -1,447,660	-76%	-$55.9M	1.03%	26
2016 Q3	$73.8M	Sell	1,900,000 -2,100,000	-53%	-$79.3M	4.5%	8
2016 Q2	$138M	Buy	+4,000,000	New	+$139M	7.55%	3

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HealthCor Management's HOLX Position: Q4 2022 in Review

HealthCor Management sold out of Hologic (HOLX) in Q4 2022, closing a stake of 137,330 shares — an estimated $8.86M sold.

HealthCor Management first reported a position in HOLX in Q2 2016 and held it in 11 quarters. The position peaked at $138M in Q2 2016. 698 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

HealthCor Management reported no remaining Hologic position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 137,330 Hologic shares in Q4 2022, an estimated $8.86M.
HealthCor Management first reported a position in Hologic in Q2 2016 and held it in 11 quarters.
HealthCor Management's Hologic position peaked at $138M in Q2 2016.
698 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.